Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a study to examine the safety, effect on lung function, and frequency of symptoms
relating to cystic fibrosis during 24 weeks of treatment with the antibiotic azithromycin in
6-18 year-olds with CF who are not infected with Pseudomonas aeruginosa.
Phase:
Phase 4
Details
Lead Sponsor:
CF Therapeutics Development Network Coordinating Center
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics